A New "Non-Traditional" Antibacterial Drug Fluorothiazinone-Clinical Research in Patients with Complicated Urinary Tract Infections

• Main Authors: Nailya A. Zigangirova (Author), Nadezda L. Lubenec (Author), Vladimir B. Beloborodov (Author), Anna B. Sheremet (Author), Stanislava A. Nelyubina (Author), Nataliia E. Bondareva (Author), Konstantin A. Zakharov (Author), Sergey I. Luyksaar (Author), Sergey A. Zolotov (Author), Evgenia U. Levchenko (Author), Svetlana V. Luyksaar (Author), Ekaterina A. Koroleva (Author), Elena D. Fedina (Author), Yana V. Simakova (Author), Dmitry Yu. Pushkar (Author), Alexander L. Gintzburg (Author)
• Format: Book
• Published: MDPI AG, 2024-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

In order to combat resistance, it is necessary to develop antimicrobial agents that act differently from conventional antibiotics. Fluorothiazinone, 300 mg tablet (The Gamaleya National Research Center), is an original antibacterial drug based on a new small molecule T3SS and flagellum inhibitor. A...